TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Adesso Bioproducts AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
56,815
|
74,436
|
55,903 |
| Financial expenses |
719
|
427
|
265 |
| Earnings before taxes |
3,198
|
4,721
|
3,769 |
| Total assets |
43,966
|
56,963
|
60,531 |
| Current assets |
33,006
|
45,570
|
47,956 |
| Current liabilities |
15,915
|
29,679
|
35,557 |
| Equity capital |
27,586
|
26,737
|
24,337 |
| - share capital |
68
|
73
|
77 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
62.7%
|
46.9%
|
40.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
5.6%
|
6.3%
|
6.7% |
| Return on assets (ROA) |
8.9%
|
9.0%
|
6.7% |
| Current ratio |
207.4%
|
153.5%
|
134.9% |
| Return on equity (ROE) |
11.6%
|
17.7%
|
15.5% |
| Change turnover |
-13,047
|
21,470
|
11,778 |
| Change turnover % |
-19%
|
41%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.